Two Sigma Investments’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-11,591
| Closed | -$112K | – | 3508 |
|
|
2024
Q4 | $112K | Sell |
11,591
-1,242
| -10% | -$12K | ﹤0.01% | 2889 |
|
|
2024
Q3 | $239K | Sell |
12,833
-2,470
| -16% | -$45.9K | ﹤0.01% | 2688 |
|
|
2024
Q2 | $255K | Buy |
15,303
+1,484
| +11% | +$24.7K | ﹤0.01% | 2576 |
|
|
2024
Q1 | $240K | Buy |
13,819
+2,317
| +20% | +$40.2K | ﹤0.01% | 2577 |
|
|
2023
Q4 | $180K | Buy |
11,502
+10,005
| +668% | +$156K | ﹤0.01% | 2775 |
|
|
2023
Q3 | $74K | Buy |
+1,497
| New | +$74K | ﹤0.01% | 2698 |
|
|
2022
Q3 | – | Sell |
-3,393
| Closed | -$304K | – | 2837 |
|
|
2022
Q2 | $304K | Sell |
3,393
-1,643
| -33% | -$147K | ﹤0.01% | 1959 |
|
|
2022
Q1 | $782K | Buy |
5,036
+1,190
| +31% | +$185K | ﹤0.01% | 1774 |
|
|
2021
Q4 | $1.15M | Buy |
3,846
+2,411
| +168% | +$718K | ﹤0.01% | 1589 |
|
|
2021
Q3 | $827K | Sell |
1,435
-244
| -15% | -$141K | ﹤0.01% | 1782 |
|
|
2021
Q2 | $762K | Buy |
1,679
+122
| +8% | +$55.4K | ﹤0.01% | 1807 |
|
|
2021
Q1 | $838K | Buy |
+1,557
| New | +$838K | ﹤0.01% | 1668 |
|